Inflammatory Profiles of Children at High Risk for Atherosclerosis
Study Details
Study Description
Brief Summary
The purpose of this study is to evaluate levels of inflammatory mediators in children at risk for cardiovascular disease due to family history. We are measuring inflammatory markers in two groups of children and their parents: children with a family history of early atherosclerotic heart disease (cases), and healthy children without such a family history (controls). The design is a cross-sectional study, gathering a fasting blood sample and clinical and behavioral data on children and a parent.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Family history is a well known risk factor for early atherosclerosis. Whether inflammation plays a role in the increased risk of family history is not known. In this prospective single-center study, we are recruiting children with and without a family history of premature atherosclerotic disease, defined as occurring < 55 years in males and <65 years in females. Children are recruited primarily from a pediatric preventive cardiology clinic at Children's Hospital Boston. We measure anthropomorphic characteristics, fasting lipid profiles and inflammatory marker levels, including high sensitivity C-reactive protein (hsCRP), intracellular adhesion molecule 1 (ICAM-1), P-selectin, and tumor necrosis factor alpha receptor 2 (TNFαR2).
In this sample of high-risk overweight children, Lp(a) and inflammatory markers could reflect cardiovascular risk outside lipid profiles.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
1 Children without family history of early atherosclerosis |
|
2 Children with family history of early atherosclerosis. |
|
3 Parents of children without family history of early atherosclerosis |
|
4 Parents of children with family history of early atherosclerosis |
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age 8-21 years
-
Parent able to participate
-
Fasting state
-
Live locally
Exclusion Criteria:
-
Taking medication that may alter cholesterol levels or inflammatory state
-
Past or present inflammatory illnesses
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Children's Hospital Boston | Boston | Massachusetts | United States | 02115 |
Sponsors and Collaborators
- Boston Children's Hospital
- Sandra A. Daugherty Foundation
Investigators
- Principal Investigator: Sarah D. de Ferranti, MD MPH, Boston Children's Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 04-03-044